The PEACE-1 trial (NCT01957436) revealed that adding radiotherapy to standard of care (SOC) and abiraterone significantly ...

The Galleri test — which isn’t covered by insurance — doesn’t come cheap. At $949 a pop, it’s out of the price range of most ...

ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

Jack Hoffman died at the age of 19, following a long battle with brain cancer. He was the face of the Team Jack Foundation, ...

Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

Information on tumor mutational status was limited before the development of NGS because traditional Sanger sequencing and ...

Vivesto AB, an oncology-focused development company, today announced that ethical approval has been obtained from the US Veterinary Review Board Clinical Studies Committee ...

Women and younger Americans are being diagnosed with cancer more than ever before, according to a new report published by ...

Of note, prostate adenocarcinoma with “treatment effect” is not ... systematic/targeted biopsy, and post surgery tumor maps. 1 The primary outcome was the ability of clinicopathologic and imaging ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

Laborie Medical Technologies Corp. (Laborie), a leader in diagnostic and therapeutic medical technologies, has reached a significant milestone with its Optilume® Drug-Coated Balloon (DCB). The ...